1 active not recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
Follow NRTI: new trials by email Literature Review of NRTI trials Research Report on NRTI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. VIR-2218, VIR-3434, NRTI - Hepatitis D, Chronic | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 95 | 2022-09-17 | 2026-06-26 |
| A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors ABI-H0731, Placebo, NrtI - Chronic Hepatitis B | Phase 2 | Terminated | Assembly Biosciences | 2 | 2020-11-11 | 2022-10-20 |
Hepatitis (1) · Hepatitis B, Chronic (1) · Hepatitis D (1) · Hepatitis D, Chronic (1)
Assembly Biosciences (1) · Vir Biotechnology, Inc. (1)
New Zealand (2) · Bulgaria (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Moldova (1) · Netherlands (1) · Romania (1) · United Kingdom (1) · United States (1)
Steven Knox (1)